BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...
In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.
Zacks Investment Research on MSN
Here's how AbbVie's oncology drugs are aiding top-line growth
AbbVie ABBV has been significantly expanding its presence in the oncology space. What started initially as a two-drug ...
“LYMPHIR is an important new treatment option for the CTCL community, and its launch marks the beginning of a new chapter for Citius Oncology,” Leonard Mazur, chairman and CEO of Citius Oncology and ...
Kura Oncology remains a Strong Buy, driven by Ziftomenib's differentiated safety profile and significant AML market potential ...
Power partnership oncology at MD Anderson expands access to expert cancer care, research, and clinical trials across seven U.S. health systems.
Sara M. Tolaney, MD, MPH, will receive the 2025 American Association for Cancer Research’s Outstanding Investigator Award for ...
New grading scales for ocular adverse events in oncology improve clarity and provide drug-dose-modification recommendations, ...
UnityPoint Health names new oncology leaders to expand cancer care across Iowa ...
A scoping review identified key factors that ensure an optimal nursing work environment that supports nurses and quality patient care.
Fintel reports that on December 11, 2025, Wedbush initiated coverage of CG Oncology (NasdaqGS:CGON) with a Outperform ...
The IDEXX Cancer Dx is a new blood-based screening/diagnostic panel aimed at detecting canine lymphoma from serum or whole ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback